The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ipratroprium Bromide
Ipratroprium Bromide · IPRATROPIUM BROMIDE 21 ug/1 · Spray, Metered · Nasal · Oceanside Pharmaceuticals
NDC 68682-0398-30 · 1 BOTTLE, SPRAY in 1 CARTON / 345 SPRAY, METERED in 1 BOTTLE, SPRAY · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA076025
- TE code
- AB
- Approval date
- Mar 31, 2003
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Ipratroprium Bromide (Spray, Metered)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Oceanside Pharmaceuticals | IPRATROPIUM BROMIDE 21 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Ipratroprium Bromide — NDC 68682-0398-30," retrieved September 3, 2026, https://drugdashboards.com/drug/68682039830.
Free to cite with attribution — see how the data is put together.